Invention Grant
- Patent Title: Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour
-
Application No.: US15969422Application Date: 2018-05-02
-
Publication No.: US10758514B2Publication Date: 2020-09-01
- Inventor: Wai Liu , Katherine Scott , Angus Dalgleish , Marnie Duncan , Colin Stott
- Applicant: GW Pharma Limited
- Applicant Address: GB Salisbury
- Assignee: GW Pharma Limited
- Current Assignee: GW Pharma Limited
- Current Assignee Address: GB Salisbury
- Agency: Morrison & Foerster LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2c5a20a7
- Main IPC: A61K31/352
- IPC: A61K31/352 ; A61P35/00 ; A61K36/185 ; A61K31/05
Abstract:
The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.
Public/Granted literature
Information query
